)
Cognition Therapeutics (CGTX) investor relations material
Cognition Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting officially called to order and held in an all-virtual format to maximize stockholder participation.
Directors, executive officers, and representatives from the independent accounting firm introduced.
Rules of conduct and procedures for participation and voting explained, with emphasis on orderly conduct and agenda-focused questions.
Notice of meeting and quorum confirmed, with voting procedures outlined for stockholders.
Board and executive committee updates
Board members and executive officers present, including chairs of audit, compensation, and governance committees.
Shareholder proposals
Proposal one: Election of class two directors to serve three-year terms until the 2029 annual meeting.
Proposal two: Ratification of EY as independent registered public accounting firm for the 2026 fiscal year.
- Oral therapy for Lewy body dementia psychosis shows strong efficacy and safety in phase II trials.CGTX
Jefferies Global Healthcare Conference 20264 Jun 2026 - Advancing zervimesine for DLB psychosis with strong efficacy, safety, and regulatory support.CGTX
Investor presentation4 Jun 2026 - Q1 2026 net loss narrowed to $4.6M as R&D costs fell, with $31.2M cash and clinical progress.CGTX
Q1 20268 May 2026 - Board recommends director elections and auditor ratification, highlighting governance and ESG.CGTX
Proxy filing27 Apr 2026 - Director elections and auditor ratification headline the June 2026 virtual annual meeting.CGTX
Proxy filing27 Apr 2026 - Phase III trials for zervimesine in DLB psychosis and Alzheimer's are advancing with strong safety and efficacy data.CGTX
25th Annual Needham Virtual Healthcare Conference13 Apr 2026 - Zervimesine demonstrated robust efficacy and safety in DLB and AD, advancing to Phase 3 with strong funding.CGTX
Corporate presentation2 Apr 2026 - Strong Phase II data and improved financials support late-stage trials in DLB and Alzheimer's.CGTX
Q4 202526 Mar 2026 - CT-1812 slowed Alzheimer's decline by 39%; cash runway into Q2 2025, more funding needed.CGTX
Q2 20242 Feb 2026
Next Cognition Therapeutics earnings date
Next Cognition Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)